Skip to main content
Premium Trial:

Request an Annual Quote

Twist Bioscience, Pure Biologics Partner on Antibody Discovery for Immunoncology

NEW YORK – Twist Bioscience said on Wednesday it has partnered with Poland's Pure Biologics on phage display libraries to accelerate antibody-based drug discovery.

Under the terms of their agreement, Twist's biopharma division will grant Pure Biologics access to select synthetic antibody phage display libraries. The companies will work together to discover, validate, and optimize new antibody candidates against useful targets for immunoncology applications.

Pure Biologics will pay Twist annual technology access fees in addition to future payments for preclinical, clinical, and commercial milestones for any antibodies resulting from the collaboration. Other financial details were not disclosed.

"We look forward to augmenting Pure Biologics' immunoncology pipeline with first-in-class bispecific antibodies identified and designed using our robust discovery and optimization engine," Twist CEO and Cofounder Emily Leproust said in a statement. "Highly selective, potent bispecific antibodies that bind to multiple targets have the potential to change the way cancer is treated in the future."

South San Francisco, California-based Twist signed a phage display library access and antibody development deal with Takeda Pharmaceutical Company in July 2020.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.